z-logo
open-access-imgOpen Access
Antiprotozoal Compounds from Urolepis hecatantha (Asteraceae)
Author(s) -
Orlando G. Elso,
María E. Pedreira,
Natalia M. Hernández,
Tomás Sgarlata,
Hernán Gerónimo Bach,
César A.N. Catalán,
Elena Aguilera,
Guzmán Álvarez,
Valeria P. Sülsen
Publication year - 2021
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2021/6622894
Subject(s) - antiprotozoal , leishmania infantum , trypanosoma cruzi , dichloromethane , chemistry , chromatography , ic50 , fractionation , asteraceae , stereochemistry , traditional medicine , in vitro , biology , leishmaniasis , solvent , biochemistry , parasite hosting , botany , medicine , visceral leishmaniasis , world wide web , computer science , immunology
The dewaxed dichloromethane extract of Urolepis hecatantha and the compounds isolated from it were tested for their in vitro activity on Trypanosoma cruzi epimastigotes and Leishmania infantum promastigotes. The extract of U. hecatantha showed activity against both parasites with IC 50 values of 7  µ g/mL and 31  µ g/mL, respectively. Fractionation of the dichloromethane extract led to the isolation of euparin, jaceidin, santhemoidin C, and eucannabinolide. The sesquiterpene lactones eucannabinolide and santhemoidin C were active on T. cruzi with IC 50 values of 10 ± 2  µ M (4.2  µ g/mL) and 18 ± 3  µ M (7.6  µ g/mL), respectively. Euparin and santhemoidin C were the most active on L. infantum with IC 50 values of 18 ± 4  µ M (3.9  µ g/mL) and 19 ± 4  µ M (8.0  µ g/mL), respectively. Eucannabinolide has also shown drug-like pharmacokinetic and toxicity properties.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom